BIOCON Share Price Target 2050

CAGR-based price projection for Biocon Limited (BIOCON) targeting 2050, derived from official NSE exchange closing prices.

Bear Case (2.5% CAGR)
Rs 676
2050 Target
Base Case (6.3% CAGR)
Rs 1,621
2050 Target
Bull Case (17.0% CAGR)
Rs 16,069
2050 Target

Current Market Snapshot

CMP: Rs 370.70
52W High: Rs 440.70
52W Low: Rs 345.00
1Y CAGR: 13.1%
3Y CAGR: 6.3%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 380 Rs 394 Rs 434
2028 Rs 390 Rs 419 Rs 507
2029 Rs 400 Rs 446 Rs 594
2030 Rs 410 Rs 474 Rs 695
2031 Rs 420 Rs 504 Rs 813
2032 Rs 431 Rs 536 Rs 951
2033 Rs 442 Rs 570 Rs 1,113
2034 Rs 453 Rs 606 Rs 1,302
2035 Rs 464 Rs 645 Rs 1,524
2036 Rs 476 Rs 685 Rs 1,783
2037 Rs 488 Rs 729 Rs 2,086
2038 Rs 501 Rs 775 Rs 2,441
2039 Rs 513 Rs 824 Rs 2,856
2040 Rs 526 Rs 877 Rs 3,341
2041 Rs 540 Rs 932 Rs 3,909
2042 Rs 553 Rs 991 Rs 4,574
2043 Rs 567 Rs 1,054 Rs 5,352
2044 Rs 582 Rs 1,121 Rs 6,262
2045 Rs 597 Rs 1,192 Rs 7,327
2046 Rs 612 Rs 1,267 Rs 8,573
2047 Rs 627 Rs 1,348 Rs 10,031
2048 Rs 643 Rs 1,433 Rs 11,737
2049 Rs 659 Rs 1,524 Rs 13,733
2050 Rs 676 Rs 1,621 Rs 16,069

Other BIOCON Price Targets

2025 2026 2027 2028 2030 2035 2040

Frequently Asked Questions

What is the BIOCON share price target for 2050?

Based on historical growth analysis, the BIOCON share price target for 2050 ranges from Rs 676 (conservative) to Rs 1,621 (base case) to Rs 16,069 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of BIOCON?

The current market price of BIOCON (Biocon Limited) is Rs 370.70. The 52-week high is Rs 440.70 and 52-week low is Rs 345.00.

Is BIOCON a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for BIOCON price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 2.5% CAGR), Base (6.3% CAGR), and Bull (optimistic at 17.0% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.